ICD-10-CM Billable Code

F13.25

Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F13.25 refers to a substance dependency involving sedatives, hypnotics, or anxiolytics, which is complicated by a psychotic disorder induced by these medications. This condition occurs when an individual develops a physical or psychological reliance on these drugs and experiences psychotic symptoms as a result. Such dependence can significantly impact a person's mental health and daily functioning, making recognition and understanding crucial. In this article, we'll explore the causes, symptoms, diagnosis, and treatment options associated with this condition.

Causes & Symptoms

Clinical Causes: Repeated or prolonged use of sedatives, hypnotics, or anxiolytics, especially in higher doses or for extended periods. Use of these medications without medical supervision or beyond prescribed dosages. Pre-existing mental health issues that increase susceptibility to dependence. History of substance abuse or dependence on other drugs. Psychosocial factors such as stress, trauma, or environmental influences that may lead to misuse. Genetic predisposition affecting how the body processes these medications.

Key Symptoms: Psychotic symptoms such as hallucinations (seeing or hearing things that aren't there). Delusions or false beliefs not based in reality. Disorganized thinking or speech. Agitation or restlessness. Changes in behavior, including agitation or hostility. Physical signs of dependence like withdrawal symptoms when not using the drug. Memory issues or confusion. Sleep disturbances related to medication use or withdrawal.

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a comprehensive clinical assessment by a healthcare professional. The process typically includes a review of medical history, substance use history, and a physical examination. Diagnostic criteria from mental health manuals, such as the DSM-5, may be employed to evaluate the presence of substance dependence coupled with psychotic features. Additional investigations like laboratory tests may be performed to rule out other conditions or substance interactions. Fully understanding the patient's medication regimen and patterns of use is essential for an accurate diagnosis.

Treatment Protocols: Treating sedative, hypnotic, or anxiolytic dependence with associated psychotic disorder is complex and usually involves a combination of approaches: - **Detoxification:** Managed withdrawal under medical supervision to safely reduce or stop medication use. - **Psychotherapy:** Including cognitive-behavioral therapy (CBT) to address dependency behaviors and psychotic symptoms. - **Medication management:** Use of alternative medications or antipsychotics to control psychotic symptoms. - **Support groups:** Participation in peer support communities to facilitate recovery. - **Addressing underlying issues:** Tackling mental health conditions or psychosocial factors contributing to medication misuse. A multidisciplinary team is often involved to develop a personalized treatment plan, aiming to reduce harm, ensure safety, and promote recovery.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F13.25 a billable ICD-10 code?
Yes, F13.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F13.25?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference